Key Stats for Humana Stock
- Price change for Humana stock: 11%
- $HUM Stock Price as of Apr. 6: $183
- 52-Week High: $315
- $HUM Stock Price Target: $212
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
What Happened?
Humana (HUM) stock surged roughly 11% after the Centers for Medicare and Medicaid Services (CMS) finalized a 2.48% rate increase for Medicare Advantage plans in 2027.
- The news sent the entire managed care sector higher.
- UnitedHealth gained 8%, CVS Health rose 7%, and Elevance Health climbed 7%.
- The final rates are a big deal because they were notably better than what CMS proposed back in January.
- In total, the update is projected to funnel over $13 billion in additional payments to Medicare Advantage plans in 2027.
- To put that in context, these rates help determine how more than half a trillion dollars move through private health insurance each year.
The announcement also addressed a few technical changes.
- Starting in 2027, CMS will stop using “unlinked chart review” records to calculate risk scores.
- This change is expected to hit insurers that rely heavily on that type of coding more than others.
- CMS also updated its Part D drug plan model to reflect changes from the Inflation Reduction Act.
CMS Administrator Dr. Mehmet Oz summed it up simply: the goal is to keep coverage affordable and make sure patients get real value from their plans.
See analysts’ growth forecasts and price targets for Humana stock (It’s free) >>>
What the Market Is Telling Us About Humana Stock
Humana stock had been under pressure heading into this announcement. Stock is down almost 30% in 2026.
The company warned investors earlier this year about a significant headwind from weaker Star Ratings in 2026, which directly affects bonus payments.
Better-than-expected final rates give Humana stock some breathing room as management works toward its 2028 earnings targets.
On their Q4 earnings call, CEO Jim Rechtin was clear that the company will adapt to whatever rate environment CMS sets.
With the final rates now confirmed to be more favorable, that job just got a little easier.
Humana stock still faces real challenges, including margin pressure and a large new member cohort to integrate.
But today’s news removes one significant uncertainty for investors watching the stock closely.
Estimate a company’s fair value instantly (Free with TIKR) >>>
How Much Upside Does Humana Stock Have From Here?
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
